MedPath

Effects of indigestible dextrin on postprandial glucose level ,lipid value and incretin secretion in healty subjects and type 2 diabetic patients

Not Applicable
Recruiting
Conditions
Diabetes
Registration Number
JPRN-UMIN000003186
Lead Sponsor
Graduate School of Medicine, Yokohama City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients who are receiving insulin therapy. 2.Patients who have a severe hepatic dysfunction. 3.Patients who have a severe renal dysfunction.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
postprandial incretin secretion
Secondary Outcome Measures
NameTimeMethod
1.postprandial glucose level 2.postprandial lipid level 3.postprandial insulin secretion
© Copyright 2025. All Rights Reserved by MedPath